Effects of Propranolol on Neurodevelopmental Outcomes in Patients with Infantile Hemangioma: A Case-Control Study

Table 4

Factors influencing the scores of each domain in the patient .

Variable	Adaption		Gross motor		Fine motor		Language functioning		Personal social functioning
	values (95% CI)		values (95% CI)		values (95% CI)		values (95% CI)		values (95% CI)
Gender	0.058 (−5.812–8.184)	0.732	−0.119 (−11.689–6.091)	0.526	0.088 (−6.722–10.976)	0.627	−0.109 (−11.332–5.950)	0.530	0.101 (−9.666–16.939)	0.581
Age at initiation of therapy	0.154 (−18.479–20.308)	0.924	0.397 (−21.955–27.319)	0.826	−0.712 (−29.5031–19.544)	0.682	1.884 (−10.508–37.386)	0.261	2.644 (−9.515–64.214)	0.140
Age at neurodevelopment test	−0.653 (−23.404–15.031)	0.660	−0.586 (−28.696–20.130)	0.723	0.255 (−22.373–26.228)	0.873	−1.516 (−35.439–12.020)	0.322	−2.218 (−61.368–11.690)	0.175
The duration of treatment	0.241 (−18.132–20.549)	0.899	0.399 (−22.291–26.848)	0.851	−0.718 (−28.707–20.205)	0.725	−2.445 (−9.113–38.649)	0.217	3.144 (−9.666–16.939)	0.581

stepwise regression analyses were used to identify the main risk factors; CI: confidence interval.